Company Search:
Advanced Search
Sponsored Links
Evolva Holding SA Company Snapshot
Evolva Holding SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Evolva Holding SA with three other miscellaneous service companies in Europe: Genfit of France (2018 sales of 7.49 million Euro [US$8.22 million] of which 100% was Therapeutic Drugs), MediGene AG of Germany (7.75 million Euro [US$8.50 million] of which 77% was Immunotherapies), and C4X Discovery Holdings PLC which is based in the United Kingdom (£7.06 million [US$8.63 million] ).

Sales Analysis. Evolva Holding SA reported sales of 8.93 million Swiss Francs (US$8.97 million) for the year ending December of 2018. This represents an increase of 30.5% versus 2017, when the company's sales were 6.85 million Swiss Francs. Despite this increase, sales are still below the level achieved in 2016, when Evolva Holding SA reported sales of 9.58 million Swiss Francs. The sales level in 2018 was fairly close to the level five years ago: in 2013, Evolva Holding SA had sales of 8.71 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Evolva Holding SA
  Stock Performance Chart for Evolva Holding SA
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .16
(Figures in Swiss Francs)
1 Week -3.6%   13 Weeks -11.4%  
4 Weeks -17.8%   52 Weeks -41.7%  
Evolva Holding SA Key Data:
  Ticker: EVE Country: Switzerland
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 8,932,700
(Year Ending Jan 2019).
Employees: 67
  Currency: Swiss Francs Market Cap: 123,965,765
  Fiscal Yr Ends: December Shares Outstanding: 773,818,759
  Share Type: STAMMAKTIEN Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.